Basket, Umbrella, and Platform Trials: The Potential for Master Protocol-Based Trials in Inflammatory Bowel Disease

Affiliations

• ¹ INFINY Institute, Nancy University Hospital, Vandœuvre-lès-Nancy, France; School of Immunology and Microbial Sciences, King's College, London, United Kingdom.
• ² Dr Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
• ³ Division of Gastroenterology, Department of Medicine, Schulich School of Medicine, Western University, London, Ontario, Canada; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.
• ⁴ Department of Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.
• ⁵ Assistance Publique-Hopitaux de Paris, Lariboisiere Fernand-Widal Hospital, Paris, France.
• ⁶ INFINY Institute, Nancy University Hospital, Vandœuvre-lès-Nancy, France; Department of Gastroenterology, Nancy University Hospital, Vandœuvre-lès-Nancy, France; FHU-CURE, Nancy University Hospital, Vandœuvre-lès-Nancy, France; INSERM, NGERE, University of Lorraine, Nancy, France; Groupe Hospitalier privé Ambroise Paré-Hartmann, Paris IBD Center, Neuilly sur Seine, France; Division of Gastroenterology and Hepatology, McGill University Health Centre, Montréal, Québec, Canada.